Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Lymphoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 9Melphalan 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 7Busulfan 7Flow Cytometry 6Filgrastim 6Nuclear Medicine Department, Hospital 5Methylprednisolone 5Carboplatin 5Biopsy 5Therapeutics 4Radiotherapy 4Psychiatric Rehabilitation 4Ipilimumab 4Etoposide 4Antilymphocyte Serum 4Alemtuzumab 4fludarabine 3Topotecan 3Thiotepa 3Stem Cell Transplantation 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Immunologic Techniques 3Crizotinib 3Caspofungin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Indocyanine Green × Lymphoid × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡